We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Konstantin M. Linnik Nutter McClennen & Fish LLP

Results 1 to 5 of 6



Court Identifies USPTO error in patent term adjustment calculations *

USA - November 15 2012
The Eastern District of Virginia recently determined in Exelixis, Inc. v. Kappos that the USPTO has been miscalculating Patent Term Adjustment in cases where a Request for Continued Examination was filed after three or more years of pendency.

Co-authors: David J. Powsner, John J. Penny, Lisa Adams, William C. Geary, Ronald E. Cahill.


USPTO and EPO to launch Cooperative Patent Classification *

European Union, USA - November 15 2012
The USPTO and the European Patent Office will launch the Cooperative Patent Classification scheme on January 1, 2013.

Co-authors: David J. Powsner, John J. Penny, Lisa Adams, William C. Geary, Ronald E. Cahill.


The US health care law: what’s next for stakeholders *

USA - July 9 2012
In a widely publicized recent health care ruling, the Supreme Court largely upheld the Patient Protection and Affordable Care Act (ACA)

Co-authors: Maria D. Buckley, Robin Morse.


Supreme Court remands Myriad for reconsideration in light of Mayo *

USA - March 28 2012
Following close on the heels of last week’s controversial decision in Mayo Collaborative Services v. Prometheus Laboratories, the United States Supreme Court sent another hotly contested biotech case back down for further consideration by a lower federal court.

Co-authors: Lydia G. Olson, Thomas J. Engellenner, Padma Choudry .


Supreme Court holds Prometheus’ diagnostic method claim unpatentable *

USA - March 21 2012
On March 20, 2012, the United States Supreme Court unanimously reversed the Federal Circuit in a long-awaited decision that may have broad-reaching effects on diagnostic method patents, as well as personalized medicine patents.

Co-authors: Lydia G. Olson, Thomas J. Engellenner, Reza Mollaaghababa, George A. Xixis, Padma Choudry .


Next »